|
Click here to view online. Add this email to your safelist. |
|||||||||||
|
|
|||||||||||
|
AstraZeneca ranked in top three in the Access to Medicine Index |
|||||||||||
|
|
|||||||||||
|
15 November 2022
AstraZeneca’s top three position in the 2022 Access to Medicine Index (AtMI) reflects the Company’s leading work to strengthen global health systems, as well as increase equitable and affordable patient access to life-changing treatments. |
|||||||||||
|